On November 27, 2024, fosun pharma conducted a share buyback on the Hong Kong Stock Exchange, purchasing 287,500 H-shares. The price per share for this buyback ranged from HKD 14.06 to HKD 14.44, with a total payment of approximately HKD 4,103,918.75. The repurchased shares will be held as treasury shares and are not planned to be canceled. This buyback is conducted under the repurchase authorization approved on June 26, 2024, with a total authorized repurchase quantity of 55,194,050 shares. After the buyback, the total number of issued shares of fosun pharma remains unchanged at 551,940,500 shares. The company will suspend the issuance of new shares and the sale of treasury shares for the next 30 days.

On November 27, 2024, fosun pharma conducted a share buyback on the Hong Kong Stock Exchange, purchasing 287,500 H-shares. The price per share for this buyback ranged from HKD 14.06 to HKD 14.44, with a total payment of approximately HKD 4,103,918.75. The repurchased shares will be held as treasury shares and are not planned to be canceled. This buyback is conducted under the repurchase authorization approved on June 26, 2024, with a total authorized repurchase quantity of 55,194,050 shares. After the buyback, the total number of issued shares of fosun pharma remains unchanged at 551,940,500 shares. The company will suspend the issuance of new shares and the sale of treasury shares for the next 30 days.